Windward Road captured the INSPORTS All-Age & Junior High Athletics Championships crown for a fourth straight year at the Stadium East field yesterday. The champions tallied 503 points to top the meet by a mere five points over rivals John Mills who ended on 498. Oral Whilby, coach of Windward Road, said he was very happy with his team’s performance because they had to fight very hard to win it. “We fought very hard for this victory because we only won it by five points,” said Whilby. “I must lift my hat off to my athletes and everyone involved because it was a very difficult victory,” he said. Windward Road trailed John Mills by 19.5 points entering yesterday’s final day of the three-day, but despite this, Whilby said he was always confident that they would have come out on top. “These athletes are champions and that champion spirit that they have in them just came to the fore at the right time and so they never panicked,” Whilby said. The top two were followed by Constant Spring (326), Swallowfield (211.50), Cockburn Gardens (206.50), Shortwood (204), New Day (198), Mico Practising (158), and Calabar (134). In yesterday’s action, Windward Road’s Amanda Spaulding won the girls’ Class One long jump with a leap of 4.91m ahead of her teammate Moesha Thompson (4.39m). Teneisha Morris of Mico Practising was third with a mark of 4.21m. Jahiem Scott of John Mills won the boys’ Class Two long jump with a mark of 5.48m in front of his teammate Leo-Paul Foster (5.46m) and Constant Spring’s Javaugh Walters (5.36m). Calabar’s Naseem Clarke captured the Class One boys 100m in 11.77 seconds defeating Antonio Phillips of Constant Spring (11.85) and Calabar’s Raheim Hamilton (11.93). John Mills’ Antonio Hylton won the boys’ Class One 400m in 54.44 seconds ahead of Windward Road’s Vishaugn Gayle (55.67) and Jahvanie Percy of Cockburn Gardens (55.79). John Mills also took home the gold medal in the girls’ equivalent when Shaniece Benjamin won in 1:02.75. Windward Road’s Amanda Spaulding was second in 1:03.27 while third went to Christopher Shieed of Constant Spring in 1:13.57. Champion athletes
President David Granger on Thursday met with a technical team from the United Nations Development Programme (UNDP) to discuss the management of Guyana’s biodiversity wealth within the Government’s ‘green’ agenda, in addition to establishing a new department of environment.The meeting which was held at the Ministry of the Presidency was led by new UNDP Resident Representative, Mikiko Tanaka and included UNDP’s Policy Specialist, Finance, Massimiliano Riva and Regional Technical Advisor of the Reducing Emissions from Deforestation and forest Degradation (REDD) Programme, Marco Chiu.President David Granger conversing with UNDP Resident Representative Mikiko TanakaThe meeting was in response to a request made by the President to the UNDP for the provision of technical assistance for the creation of a holistic strategy that encompasses the country’s forests, wildlife and other natural resources as the Government moves to further its green agenda.“The low carbon development strategy in my view is too narrow. We need to go back to the drawing board to develop something that takes into account coastal zone management, wildlife protection, our biodiversity,” President Granger said.Additionally, the team over the course of the next few days, will be discussing with a Guyanese delegation, the establishment of a department of environment. President Granger explained that there is need to separate biodiversity protection and management from the extractive industries, both of which currently fall under the purview of the Natural Resources Ministry.
THOUSAND OAKS – Amgen Inc.’s latest cancer fighter turned out to be an even better warrior than it expected, the biotech giant announced Thursday. The company co-developed panitumumab to fight metastatic colorectal cancer with Fremont-based Abgenix Inc., receiving fast-track designation from the U.S. Food and Drug Administration in July. In the recently completed study, the companies expected one-third of patients to survive with no progression of symptoms. After testing it on 463 patients who had not improved after chemotherapy, they were surprised to find that 46 percent instead survived without their symptoms progressing. “We saw some tumor shrinkage and, in addition, we slowed the rate of tumor progression,” said Trish Hawkins, a spokeswoman for Amgen. “It’s exciting, because it potentially offers a new option.” The deal between companies goes back 10 years, when Abgenix partnered with Immunex. Amgen purchased the latter company and continued the agreement in 2003, agreeing to handle development and commercialization, while Abgenix manufactures the drug. The companies, which split costs and profits equally, hope to win FDA approval for a launch in 2006. 160Want local news?Sign up for the Localist and stay informed Something went wrong. Please try again.subscribeCongratulations! You’re all set! AD Quality Auto 360p 720p 1080p Top articles1/5READ MOREWalnut’s Malik Khouzam voted Southern California Boys Athlete of the Week Colorectal cancer is the third most common kind of cancer in America, with 100,000 new cases diagnosed annually. “It’s exciting news for the company and important news for cancer patients,” said Greg Mann, director of corporate communications for Abgenix. “It gives them an alternative when they’ve failed with chemotherapy.” Shares of Amgen moved up $3.61, or 4.9 percent, to close at $77.51 after release of the news Thursday morning. Abgenix added $3.53, or 38 percent, to close at $12.90. Brent Hopkins, (818) 713-3738 [email protected]